Novel vaccine platform improved protection against diverse influenza subtypes when tested in animal models and human ...
The TRACeR I platform was incorporated into a humanized antibody fragment in a bispecific T-cell engager (BiTE) format. When ...
Antibodies, also known as immunoglobulins, work by binding to the surface of the antigen, stimulating the ... varieties are also sometimes found in tests for RF. Rheumatoid arthritis arises ...
Knowing your blood type is more important than you think. Here's why and tips for finding yours before an emergency happens.
AIIMS researchers claim to have made significant progress in developing chimeric antigen receptor (CAR) T-cell therapy, ...
Microbix will continue driving sales growth across all of its business lines, while working to keep improving percentage ...
Host genetics play a significant role in shaping immune responses to different strains in the influenza vaccine, ...
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large drop in short interest in the month ...
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal ...
AIIMS Delhi has achieved a groundbreaking milestone in cancer treatment by developing an antibody-based therapy for recurrent cancers, specifically M ...
This second binding, with the coalescence of the antigen–antibody complexes, produces the appearance of a colored line and indicates a positive test. Most assays also have a positive control ...